FDA Peptide Reclassification 2026: What It Means for Providers The Peptide Ban Is Ending: FDA Peptides Explained Apple Podcasts Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to The internet says BPC 157 is banned the FDA says something more nuanced. At Moonshot Medical in Park Ridge, IL, we provide honest, current guidance on peptide therapy through licensed compounding pharmacies. When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few